Expanding Access: Models for Opt-Out Testing in Emergency Departments
Emergency departments are uniquely positioned to expand access to HIV, hepatitis C, and syphilis testing. HealthHIV’s “Touch Points” quality improvement initiative has demonstrated that there is interest and capacity among diverse emergency departments (EDs) nationwide to expand HIV testing, and that individualized technical assistance paired with funding mechanisms can facilitate implementation of opt-out testing in EDs.
This webinar will share interim data and lessons learned from the “Touch Points” opt-out testing and linkage to care initiative, and explore benefits and limitations of different models for opt-out HIV testing implementation. Emergency Medicine Physician and Director of Population Health & Health Services, Michael Lyons MD, MPH, will review key considerations for workflow integration, staff engagement, and sustainability. Attendees will leave with real-world insights and actionable strategies to adapt and strengthen opt-out HIV testing efforts in their own emergency medicine settings.
Educational Objectives
After completing this activity, the participant should be better able to:
- Summarize lessons learned from the “Touch Points” opt-out testing initiative in emergency departments (EDs)
- Explore implementation models for opt-out HIV, and pan-viral, testing in EDs
- Identify potential challenges and opportunities for implementing opt-out testing in EDs
Target Audience
Primary care providers, pharmacists, nurses, nurse practitioners, physician associates, social workers, and other healthcare professionals in involved in the testing, identification and linkage to care for individuals with HIV, HBV, HCV, and STIs at student health centers, emergency departments, urgent care clinics, and other non-traditional settings.
Accreditation, Credit, and Support
IIn support of improving patient care, this activity has been planned and implemented by Medical Learning Institute Inc, and HealthHIV. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Media
- Enduring Material
Release Date
- November 19, 2025
Expiration Date
- November 19, 2026
Time to Complete
- 60 minutes
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME’s Program and Activity Reporting System (PARS).
The European Union of Medical Specialists-European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) has an agreement of mutual recognition of continuing medical education (CME) credit with the American Medical Association (AMA). European physicians interested in converting AMA PRA Category 1 Credit™ into European CME credit (ECMEC®) should contact the UEMS (www.uems.eu).
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour.
Medical Learning Institute Inc designates this application-based continuing education activity for 1.0 contact hour (0.1 CEU) of the Accreditation Council for Pharmacy Education.
UAN: JA0007322-9999-25-050-L01-P.
As a Jointly Accredited Organization, Medical Learning Institute Inc (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 clinical social work continuing education credit.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute Inc, the accredited provider, and HealthHIV, the joint provider, do not have any relevant financial relationships to disclose with ineligible companies unless listed below.
Disclosure and Conflict of Interest Policy
Medical Learning Institute Inc and HealthHIV are committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, MLI requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to MLI policy. These disclosures will be provided to learners prior to the start of the CE activity.
Faculty Disclosures
- Michael Lyons, MD, MPH
[tbd]
All of the relevant financial relationships of individuals for this activity have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity, however registration is required. In order to receive credit, learners must participate in the entire CE activity. A statement of credit will be issued only upon receipt of a completed activity evaluation and will be emailed to you upon completion. You will receive your certificate from HealthHIV. If you have questions regarding your certificate, please contact Shannon Morgan via email at [email protected].
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 80% or higher is needed to obtain MOC credit.For Pharmacists, MLI will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
Medical Learning Institute Inc and HealthHIV are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of Medical Learning Institute Inc and HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of Medical Learning Institute Inc or any of its partners, providers, and/or supporters.
Other Related Trainings
HIV & Comorbidities: Understanding the Intersection of HIV and Other Health Conditions
This webinar examines the impact of co-morbidities such as diabetes, cardiovascular disease, mental health disorders, and hepatitis on individuals living with HIV. Experts will discuss how these conditions intersect with HIV and influence treatment and health outcomes.
Engaging African Immigrants in HIV Prevention and Care
Engaging African Immigrants in HIV Prevention and Care is a self-paced e-learning course designed to equip healthcare and service providers with culturally responsive strategies to improve HIV prevention, testing, and care engagement among African immigrant communities.
